2305-2066

Drug development & registration

Center of Pharmaceutical Analytics Ltd

View prefix report (10.33380)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 84 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact84 DOIs
2

Add abstracts to 52 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact52 DOIs
3

Deposit reference lists for 6 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact6 DOIs

DOIs for this ISSN

Showing the top 5 of 646 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Development and Validation of Atazanavir and Ritonavir Deter… (10.33380/2305-2066-2020-9-1-99-108)
Abstract ORCID
34.95 4
2 Antimicrobial Activity of Polyphenolic Compounds (10.33380/2305-2066-2022-11-2-65-72)
Abstract
31.38 17
3 Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Spe… (10.33380/2305-2066-2022-11-2-180-186)
Abstract
27.85 12
4 Features of Microelements Express-determination in Medicinal… (10.33380/2305-2066-2019-8-2-93-97)
ORCID
26.98 11
5 Choice of Extraction Method for Receiving Extraction from Se… (10.33380/2305-2066-2019-8-3-35-39)
ORCID
26.03 10
6 Approaches to the Development of Drugs with the Use of Moder… (10.33380/2305-2066-2019-8-3-45-48)
ORCID
23.86 8
7 Validation of Chromatographic Methods: Checking the Peak Pur… (10.33380/2305-2066-2020-9-3-129-136)
Abstract
23.86 8
8 A Clinical Study of the Safety and Tolerability of Live Nasa… (10.33380/2305-2066-2021-10-1-114-119)
Abstract
23.86 8
9 Development and Validation of a Method for Determining Defer… (10.33380/2305-2066-2022-11-2-187-196)
Abstract ORCID
23.86 2
10 Comparative Study of Rheological Properties of Gels and Crea… (10.33380/2305-2066-2022-11-3-121-129)
ORCID
23.86 8
11 Comparative Analysis of Perspective Extragation Methods for… (10.33380/2305-2066-2019-8-3-49-55)
ORCID
22.58 7
12 Method of Estimating the Equivalence of Dissolution Profiles… (10.33380/2305-2066-2020-9-2-145-150)
ORCID
22.58 7
13 The Prospect of Creating Medicines Based on Selenium Nanopar… (10.33380/2305-2066-2020-9-2-33-44)
ORCID
22.58 7
14 Nitrofurans for External Use (Review) (10.33380/2305-2066-2019-8-2-38-47)
ORCID
21.13 6
15 Investigation of the Antiviral Activity of Experimental Samp… (10.33380/2305-2066-2019-8-4-9-15)
ORCID
21.13 6
16 Experimental Investigation of Immunomodulator Galavit<sup… (10.33380/2305-2066-2020-9-1-92-97)
ORCID
21.13 6
17 The Influence of Deuterium on the Properties of Pharmaceutic… (10.33380/2305-2066-2020-9-2-24-32)
ORCID
21.13 6
18 Determination of Nettle Leaves Extracts Antioxidant Activity… (10.33380/2305-2066-2020-9-3-59-66)
Abstract
21.13 6
19 Development of Dihydroquercetin-based Oral tablets and Evalu… (10.33380/2305-2066-2022-11-2-126-138)
Abstract
21.13 6
20 Study of Morphology of Sorption Substances (10.33380/2305-2066-2019-8-2-33-37)
ORCID
19.45 5
21 Research in the Development and Validation of the Method of… (10.33380/2305-2066-2019-8-2-80-86)
ORCID
19.45 5
22 Prospects for the Use of Medical Clays (Review) (10.33380/2305-2066-2019-8-4-27-31)
ORCID
19.45 5
23 Specific Influenza Therapy: Current State and Prospects (Rev… (10.33380/2305-2066-2020-9-1-83-91)
ORCID
19.45 5
24 Interpolyelectrolyte Complexes Based on Eudragit® Copolymers… (10.33380/2305-2066-2020-9-2-72-76)
ORCID
19.45 5
25 Pharmaceutical Development of «Sedoflav» Capsules, Standardi… (10.33380/2305-2066-2020-9-3-118-127)
Abstract
19.45 5
26 Development of a Liposomal Dosage Form Based on Hydrophobic… (10.33380/2305-2066-2020-9-3-21-26)
Abstract
19.45 5
27 Methods and Prospects for Determination of Mycotoxins in Med… (10.33380/2305-2066-2020-9-3-67-109)
Abstract
19.45 5
28 Development of Orodispersible Ibuprofen Tablets Based on a P… (10.33380/2305-2066-2022-11-3-113-120)
ORCID
19.45 5
29 Hypolipidemic activity of the polysaccharide L-rhamnopyranos… (10.33380/2305-2066-2022-11-3-57-63)
Abstract
19.45 5
30 Study of Desorbtion and Exemption of Terpeno-indole Alkaloid… (10.33380/2305-2066-2019-8-2-16-21)
ORCID
17.47 4
31 HPLC-Analysis of Phenolic Complex in Pectoral Species № 4 an… (10.33380/2305-2066-2019-8-2-98-102)
ORCID
17.47 4
32 The Method of Express Measurement of Moisture of Bulk Materi… (10.33380/2305-2066-2019-8-3-40-43)
ORCID
17.47 4
33 Modern Technologies of Controlled Release of Biologically Ac… (10.33380/2305-2066-2020-9-2-56-66)
ORCID
17.47 4
34 Polycomplex Carrier for Buccal Mucoadhesion Delivery of Metr… (10.33380/2305-2066-2020-9-2-83-90)
ORCID
17.47 4
35 Investigation of the Chemical Composition and Dopaminergic A… (10.33380/2305-2066-2020-9-3-143-149)
Abstract
17.47 4
36 Transfer of Analytical Procedures (Review) (10.33380/2305-2066-2020-9-3-182-187)
Abstract
17.47 4
37 Critical Points for the Production of Polymeric Microspheres… (10.33380/2305-2066-2020-9-3-28-35)
Abstract
17.47 4
38 Investigation of the Influence of Formulation Method on Tech… (10.33380/2305-2066-2022-11-2-102-108)
Abstract
17.47 4
39 Flow Dispersion for Obtaining Ivermectin Encapsulated in Pol… (10.33380/2305-2066-2022-11-2-79-86)
Abstract
17.47 4
40 Рharmaceutical-technological Study of Adsorbed Liquid Plant… (10.33380/2305-2066-2022-11-2-94-101)
Abstract
17.47 4
41 Risk-based Approach in Obtaining and Analysing the Character… (10.33380/2305-2066-2022-11-3-47-56)
Abstract
17.47 4
42 Profile of biologically active substances of <i>Aronia… (10.33380/2305-2066-2024-13-2-1715)
Abstract
17.47 4
43 Evaluation of Glycyrrhizic Acid Content in Licorice Roots an… (10.33380/2305-2066-2019-8-2-87-91)
ORCID
15.05 3
44 Evaluation of Pharmacokinetical Parameters of Phenol, a Comp… (10.33380/2305-2066-2019-8-3-57-61)
ORCID
15.05 3
45 Development of Composition and Technology of Resveratrol Cap… (10.33380/2305-2066-2019-8-4-16-19)
ORCID
15.05 3
46 Comparative Analysis of the QbD Approach in the Pharmaceutic… (10.33380/2305-2066-2019-8-4-20-26)
ORCID
15.05 3
47 Comparative Characteristics of Determination of Antioxidant… (10.33380/2305-2066-2019-8-4-48-52)
ORCID
15.05 3
48 Tablet Development for a Hydroscopic Drug Using Solid Disper… (10.33380/2305-2066-2020-9-1-23-28)
ORCID
15.05 3
49 Development and Validation of Valganciclovir and its Active… (10.33380/2305-2066-2020-9-2-133-139)
ORCID
15.05 3
50 Immunogenicity Assessment of Pegfilgrastim in Patients with… (10.33380/2305-2066-2020-9-2-140-144)
ORCID
15.05 3